Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cannabis
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Oropharyngeal
100%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
55%
Marijuana
55%
Nasopharyngeal mucosa
44%
Viral Persistence
33%
Papillomavirus Infections
33%
Specific Intent
22%
Viral Infection
22%
MmuPV1
22%
Cannabidiol
22%
In Vivo Assay
11%
Histological Analysis
11%
Human Cancer
11%
Sexually Transmitted Infections
11%
Human Papillomavirus Vaccine
11%
Cannabis Use
11%
Circumvallate Papillae
11%
Mouse Papillomavirus
11%
Developed Countries
11%
Control Variables
11%
Imaging Systems
11%
Innate Immune Cells
11%
Infected Tissue
11%
Newly Established
11%
Cervical Cancer
11%
District of Columbia
11%
White People
11%
Knowledge Gaps
11%
Recreational Use
11%
Clinically Significant
11%
Immunoblot Analysis
11%
Toponome
11%
Virological Analysis
11%
Immune Landscape
11%
Medicine and Dentistry
Wart Virus
100%
Papillomaviridae
100%
Cannabis
100%
Diseases
100%
Cancer
62%
Papillomavirus Infection
37%
Cannabis Use
37%
Smoke
25%
Cannabidiol
25%
Virus Infection
25%
Oropharynx Carcinoma
25%
Malignant Neoplasm
12%
Immunocompetent Cell
12%
In Vitro
12%
Wart Virus Vaccine
12%
Cervical Cancer
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabis
100%
Papillomaviridae
100%
Diseases
100%
Human Papillomavirus
80%
Papillomavirus Infection
30%
Oropharynx Cancer
20%
Virus Infection
20%
Cannabidiol
20%
Oropharynx Carcinoma
20%
Malignant Neoplasm
10%
Wart Virus Vaccine
10%
Uterine Cervix Cancer
10%